243 related articles for article (PubMed ID: 1690258)
1. Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour.
Rönnblom LE; Alm GV; Oberg KE
J Intern Med; 1990 Mar; 227(3):207-10. PubMed ID: 1690258
[TBL] [Abstract][Full Text] [Related]
2. Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity.
Oberg K; Alm G; Magnusson A; Lundqvist G; Theodorsson E; Wide L; Wilander E
J Natl Cancer Inst; 1989 Apr; 81(7):531-5. PubMed ID: 2466128
[TBL] [Abstract][Full Text] [Related]
3. Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results.
Oberg K; Norheim I; Lind E; Alm G; Lundqvist G; Wide L; Jonsdottir B; Magnusson A; Wilander E
Cancer Treat Rep; 1986 Nov; 70(11):1297-304. PubMed ID: 2429764
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of metastasized carcinoid tumor of the ileum and cecum with recombinant alpha-2b interferon].
Doberauer C; Niederle N; Kloke O; Kurschel E; Schmidt CG
Onkologie; 1987 Dec; 10(6):340-4. PubMed ID: 2450326
[TBL] [Abstract][Full Text] [Related]
5. Treatment of metastatic carcinoid tumour with recombinant interferon alfa.
Joensuu H; Kumpulainen E; Gröhn P
Eur J Cancer; 1992; 28A(10):1650-3. PubMed ID: 1382493
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-alpha treatment.
Rönnblom LE; Alm GV; Oberg K
Acta Oncol; 1991; 30(4):537-40. PubMed ID: 1854511
[TBL] [Abstract][Full Text] [Related]
7. Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested?
Välimäki M; Järvinen H; Salmela P; Sane T; Sjöblom SM; Pelkonen R
Cancer; 1991 Feb; 67(3):547-9. PubMed ID: 1702352
[TBL] [Abstract][Full Text] [Related]
8. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors.
Rönnblom LE; Alm GV; Oberg KE
Ann Intern Med; 1991 Aug; 115(3):178-83. PubMed ID: 2058872
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study.
Jacobsen MB; Hanssen LE; Kolmannskog F; Schrumpf E; Vatn MH; Bergan A
Scand J Gastroenterol; 1995 Aug; 30(8):789-96. PubMed ID: 7481548
[TBL] [Abstract][Full Text] [Related]
10. Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.
Biesma B; Willemse PH; Mulder NH; Verschueren RC; Kema IP; de Bruijn HW; Postmus PE; Sleijfer DT; de Vries EG
Br J Cancer; 1992 Nov; 66(5):850-5. PubMed ID: 1384643
[TBL] [Abstract][Full Text] [Related]
11. Interferon treatment in patients with malignant carcinoids.
Nobin A; Lindblom A; Månsson B; Sundberg M
Acta Oncol; 1989; 28(3):445-9. PubMed ID: 2742782
[TBL] [Abstract][Full Text] [Related]
12. A dose-escalation study of recombinant interferon-alpha in patients with a metastatic carcinoid tumour.
Veenhof CH; de Wit R; Taal BG; Dirix LY; Wagstaff J; Hensen A; Huldij AC; Bakker PJ
Eur J Cancer; 1992; 28(1):75-8. PubMed ID: 1373635
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of metastatic carcinoid with the somatostatin analog octreotide and with recombinant interferon alfa 2b].
Linkesch M; Kuzmits R; Geyer G
Wien Klin Wochenschr; 1989 Jun; 101(13):455-7. PubMed ID: 2763566
[TBL] [Abstract][Full Text] [Related]
15. Recombinant alpha-2b interferon in patients with malignant carcinoid tumour.
Basser RL; Lieschke GJ; Sheridan WP; Fox RM; Green MD
Aust N Z J Med; 1991 Dec; 21(6):875-8. PubMed ID: 1726359
[TBL] [Abstract][Full Text] [Related]
16. Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia.
Schilling PJ; Kurzrock R; Kantarjian H; Gutterman JU; Talpaz M
Cancer; 1991 Oct; 68(7):1536-7. PubMed ID: 1893353
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to epithelial cells in patients on long-term therapy with leucocyte-derived interferon-alpha (IFN-alpha).
Karlsson-Parra A; Burman P; Hagberg H; Oberg K; Alm G; Klareskog L; Karlsson FA
Clin Exp Immunol; 1990 Jul; 81(1):72-5. PubMed ID: 2199098
[TBL] [Abstract][Full Text] [Related]
18. Recombinant alpha-2 interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumours. A preliminary report.
Hanssen LE; Schrumpf E; Kolbenstvedt AN; Tausjø J; Dolva LO
Acta Oncol; 1989; 28(3):439-43. PubMed ID: 2742781
[TBL] [Abstract][Full Text] [Related]
19. Anti-interferon alpha treatment in SLE.
Kirou KA; Gkrouzman E
Clin Immunol; 2013 Sep; 148(3):303-12. PubMed ID: 23566912
[TBL] [Abstract][Full Text] [Related]
20. Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders.
Wandl UB; Nagel-Hiemke M; May D; Kreuzfelder E; Kloke O; Kranzhoff M; Seeber S; Niederle N
Clin Immunol Immunopathol; 1992 Oct; 65(1):70-4. PubMed ID: 1382910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]